Progression-free survival of mCRPC patients treated with AAP | Download Scientific Diagram
The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study - ScienceDirect
Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study | Journal of Nuclear Medicine
Overall Survival in mCRPC Cases Linked to Number of Radium-223 Doses - Renal and Urology News
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate | Prostate Cancer and Prostatic Diseases
Efficacy I PLUVICTO
Cancers | Free Full-Text | Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry | Prostate Cancer and Prostatic Diseases
Association between CTC AR-V7 and overall survival in mCRPC. A total... | Download Scientific Diagram
In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database - European Urology Focus
Docetaxel Rechallenge Improves Survival in Patients With Metastatic Castration-resistant Prostate Cancer: A Retrospective Study | In Vivo
Prostate cancer - The Lancet
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry.,Prostate Cancer and Prostatic Diseases - X-MOL
Overall survival and second primary malignancies in men with metastatic prostate cancer | PLOS ONE
Prediction of survival rate among studied mCRPC patients based on serum... | Download Scientific Diagram
Understanding what matters to metastatic castration‐resistant prostate cancer (mCRPC) patients when considering treatment options: A US patient preference survey - George - Cancer Medicine - Wiley Online Library
Treatment of Metastatic Castration-resistant Prostate Cancer Patients With Abiraterone Acetate and Prednisone and Corresponding Survival Prognostic Factors | Anticancer Research
Pattern of Clinical Progression Until Metastatic Castration-Resistant Prostate Cancer: An Epidemiological Study from the European Prostate Cancer Registry | SpringerLink
A-C) Overall survival of 68 patients with metastesis castration... | Download Scientific Diagram
Real World Patterns of PSA Response and Survival with Abiraterone and Enzalutamide in Metastatic Castrate Resistant Prostate Cancer (mCRPC) | Clinical Oncology and Research | Science Repository | Open Access
mCRPC: PREVAIL Trial | HCP Site | XTANDI® (enzalutamide)
Optimal sequencing of commonly used medications for treatment of metastatic castration-resistant prostate cancer - Mayo Clinic
Overall survival and second primary malignancies in men with metastatic prostate cancer | PLOS ONE
Overall survival. mCRPC metastatic castration-resistant protate cancer.... | Download Scientific Diagram
IJMS | Free Full-Text | The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone
